120734
  • Log in
The Daily Sceptic
No Result
View All Result
  • Articles
  • About
  • Archive
    • ARCHIVE
    • NEWS ROUND-UPS
  • Forum
  • Donate
  • Newsletter
The Daily Sceptic
No Result
View All Result

Re-evaluation of Pfizer Trial Data Shows Zero Efficacy, Say Experts

by Will Jones
17 June 2022 3:24 PM

The expert group HART (Health Advisory and Recovery Team) has delved into the Pfizer trial documents released following a U.S. court order and discovered that according to Pfizer’s own antibody data the vaccine efficacy in the trial was massively overstated and appears to be as low as zero.

While the official results found only eight PCR-positive ‘cases’ in the vaccine arm, Pfizer’s antibody testing shows that in fact 75 people in the vaccinated arm seroconverted (developed N-type antibodies), implying there were actually 75 ‘cases’ of Covid in the vaccinated, not just eight.

By itself that would cut efficacy in half. However, HART points out that it’s been shown with the Moderna mRNA vaccine that only around 40% of the vaccinated who go on to have a symptomatic PCR-positive Covid ‘breakthrough’ infection develop N-type antibodies, owing to immune imprinting (‘original antigenic sin’) by the vaccine to favour S-type antibodies (which target the spike protein). Assuming this also applies to the Pfizer mRNA vaccine, this means the 75 seropositive individuals are only around 40% of the total number who had Covid, giving an estimated total of 188 Covid ‘cases’ in the vaccine arm – more than the 165 in the unvaccinated arm, implying zero vaccine efficacy or worse.

How did Pfizer get away with claiming there were only eight Covid cases in the vaccinated arm? Mainly by excluding PCR-positives in the jabbed until seven days after the second dose. The problem with this is that, since Covid waves tend to infect only 10-20% of a population, evidently not everyone is equally susceptible to the virus. This means if those most susceptible to the virus in the vaccine arm catch it in the weeks before they are ‘fully vaccinated’ and so don’t count towards the vaccine arm ‘cases’, those remaining in the vaccine arm of the trial will be primarily those who are less susceptible to the virus, and so the trial will suffer from survivor bias, exaggerating efficacy.

HART explains:

Pfizer set out in its protocol that efficacy would be measured based on PCR positive test results in symptomatic individuals and, as a secondary measure, N-antibody levels showing who had been infected. 

Pfizer chose to ignore PCR positive results, even in symptomatic people, if they occurred in the month before “seven days after the second dose”. However, the antibody testing is a measure of who had Covid for the entire period of the trial. Concerns about higher incidence in the early period after dosing, or an illusion of efficacy from a drug that caused cases to occur earlier rather than preventing cases, would be addressed by measuring the numbers who developed antibodies.

The original trial claimed there were only eight symptomatic PCR positive ‘cases’ in the dosed arm compared to 162 in the placebo arm. The graph always looked odd – how could the treatment arm have such a dramatic flattening to the horizontal?

There were 165 people who started with negative antibodies but became positive during the trial in the placebo arm. That is a pretty close match to the 165 who were positive by PCR testing. However, there were 75 in the vaccine arm, far more than the eight claimed by PCR testing. That would mean that treatment only reduced the risk of infection by about half the 95% claimed.

Only 40% of people who had been given Moderna produced N-antibodies after symptomatic, PCR positive infection. Moderna and Pfizer have products that are very similar in terms of mechanism of action, so it is not unreasonable to assume that a similar issue would be seen with Pfizer. 

If that is the case, then the 75 figure would only be a fraction of the people in the treatment arm who had been infected. Assuming the 40% figure holds, that would mean that there was no efficacy from Pfizer vaccination against risk of infection when measuring the entire period from first needle to end of the trial. 

Worth reading in full.

Tags: AntibodiesCasesHARTOriginal antigenic sinPCR TestPfizerVaccine efficacyVaccines

Donate

We depend on your donations to keep this site going. Please give what you can.

Donate Today

Comment on this Article

You’ll need to set up an account to comment if you don’t already have one. We ask for a minimum donation of £5 if you'd like to make a comment or post in our Forums.

Sign Up
Previous Post

Why the FDA Should Not Have Approved the Pfizer Covid Vaccine for Infants

Next Post

France Bans Gatherings “Due to Heatwave” as Germany Mulls Annual Mask Mandate – and China Uses Covid App to Target Protestors

Subscribe
Login
Notify of
Please log in to comment

Profanity and abuse will be removed and may lead to a permanent ban.

19 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments

NEWSLETTER

View today’s newsletter

To receive our latest news in the form of a daily email, enter your details here:

 

DONATE

PODCAST

Nick Dixon and Toby Young Talk About Toby’s Appearance on the 77th Brigade’s Watch List, the Scrubbing of the Internet After the Pfizer Sting and the Trans Insanity Unfolding in Scotland

by Will Jones
31 January 2023
0

LISTED ARTICLES

  • Most Read
  • Most Commented
  • Editors Picks

News Round-Up

4 February 2023
by Will Jones

Vitamin D Cuts COVID-19 Risk of Death in Half, New Study Finds. So Why Isn’t it Recommended?

3 February 2023
by Will Jones

94% of Claims to the Government’s Vaccine Injury Payment Scheme Are Rejected, Many Because They Are Not “60% Disabled”. Mark Kerry is One of Them

3 February 2023
by Claire Hibbs

The Fightback Against the Woke Capture of Scottish Schools Begins

4 February 2023
by Stuart Waiton

Delilah Is the Latest Victim of the Woke Brigade

4 February 2023
by Nick Dixon

News Round-Up

53

94% of Claims to the Government’s Vaccine Injury Payment Scheme Are Rejected, Many Because They Are Not “60% Disabled”. Mark Kerry is One of Them

54

Vitamin D Cuts COVID-19 Risk of Death in Half, New Study Finds. So Why Isn’t it Recommended?

54

Delilah Is the Latest Victim of the Woke Brigade

26

News Round-Up

65

The Ministry of Climate Truth

3 February 2023
by Chris Morrison

The Alarming Trend in Core Mortality Since the Vaccine Rollout

3 February 2023
by Nick Bowler

99 Doctors and Medical Professionals Demand the British Heart Foundation Comes Clean About Vaccine Heart Injury ‘Cover-Up’

2 February 2023
by Will Jones

Masks Don’t Work, Gold Standard Review of Trial Data Concludes

2 February 2023
by Dr Robert Malone

Democratic Countries Must Reject This WHO Power Grab That Threatens Global Lockdowns and Vaccine Mandates

2 February 2023
by Dr David Bell

POSTS BY DATE

June 2022
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
27282930  
« May   Jul »

SOCIAL LINKS

Free Speech Union
  • Home
  • About us
  • Donate
  • Privacy Policy

Facebook

Twitter

Instagram

RSS

Subscribe to our newsletter

© Skeptics Ltd.

No Result
View All Result
  • Articles
  • About
  • Archive
    • ARCHIVE
    • NEWS ROUND-UPS
  • Forum
  • Donate
  • Newsletter

© Skeptics Ltd.

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Please note: To be able to comment on our articles you'll need to be a registered donor

Already have an account?
Please click here to login Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
wpDiscuz
You are going to send email to

Move Comment